EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploration of Novel Indole Compounds with Potential Activity Against Breast Cancer: Synthesis, Characterization and Anti-Cancer Activity Evaluation

Eid E Salama iD, Ashtar A Alrayes iD, Saad Alrashdi iD, Ahmed T A Boraei, Nagwa I Ahmed, Salah Eid, Karam S El-Nasser, Haitham Kalil iD, Ahmed A M Sarhan

Pharmaceuticals · 04.03.2026 · 19 (3) · 418

DOI: 10.3390/ph19030418 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 04.03.2026. Verfasst von Eid E Salama und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, College of Science, Jouf University, Sakaka 72341, Aljouf, Saudi Arabia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was funded by the Deanship of Graduate Studies and Scientific Research at Jouf University, Deanship of Graduate Studies and Scientific Research at Jouf University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Cancer remains one of the most significant challenges in modern medicine, requiring the continuous development of novel molecular scaffolds with anticancer potential that act through multiple pathways. Heterocyclic compounds incorporating indole, triazole, oxadiazole, and thiadiazine motifs have attracted considerable attention due to their diverse pharmacological activities. This study aimed to design, synthesize, and evaluate new hybrid heterocyclic systems, including 1,2,4-triazole, 1,3,4-oxadiazole, and thiadiazine motifs, targeting liver and breast cancer.

Methods

A series of indolyl-based heterocyclic compounds was synthesized using efficient and environmentally friendly protocols. Indolyl-triazol-thiadiazin-6-ol 5 was prepared via solvent-free fusion of esters 2 and 3 or the corresponding acid 4. Oxadiazole derivatives were produced by reacting hydrazide intermediates with carbon disulfide. Triazole derivatives were synthesized via cylization of thiosemicarbazide 9 in aqueous KOH (4.0 N). Structural characterization was performed using Fourier Transform InfraRed (FTIR), 1H and 13C NMR spectroscopy, and electron impact mass spectrometry (EIMS). Cytotoxic activity was evaluated against liver and breast cancer cell lines, and VEGFR-2 kinase inhibition was assessed for selected derivatives.

Results

The synthesized compounds demonstrated notable cytotoxicity activity, with compounds 4, 5, and 9 exhibiting IC50 values in the low micromolar range. Enzymatic assays revealed that compounds 4 and 9 showed strong VEGFR-2 inhibition (97.9% and 96.4%, respectively), indicating apoptosis-inducing effects.

Conclusions

The synthesized indolyl-based hybrid heterocycles represent a promising chemotype with in vitro cytotoxic activity and VEGFR-2 inhibitory effects, supporting further investigation, optimization, and mechanistic studies to evaluate their potential lead for anticancer drug development.

Schlagwörter

Stichwörter der Autor:innen

HepG2MCF-7anticancerindolyl-1,2,4-triazolessynthesis

Autor:innen und Institutionen

  • Department of Chemistry, College of Science, Jouf University, Sakaka 72341, Aljouf, Saudi Arabia.
  • Department of Chemistry, Faculty of Science, Suez Canal University, Ismailia 41522, Egypt.
  • Internal Medicine Department, Faculty of Medicine, Suez University, Suez 43511, Egypt.
  • Department of Chemistry & Biochemistry, California Polytechnic State University, San Luis Obispo, CA 93407, USA.
  • Department of Chemistry, Faculty of Science, Arish University, Al-Arish 45511, Egypt.

ORCID-Profile: Eid E Salama, Ashtar A Alrayes, Saad Alrashdi, Haitham Kalil

Förderung

  • This work was funded by the Deanship of Graduate Studies and Scientific Research at Jouf University
  • Deanship of Graduate Studies and Scientific Research at Jouf University

Zitieren

APA

Salama, E. E., Alrayes, A. A., Alrashdi, S., Boraei, A. T. A., Ahmed, N. I., Eid, S., El-Nasser, K. S., Kalil, H., & Sarhan, A. A. M. (2026). Exploration of Novel Indole Compounds with Potential Activity Against Breast Cancer: Synthesis, Characterization and Anti-Cancer Activity Evaluation. Pharmaceuticals, 19(3), 418. https://doi.org/10.3390/ph19030418

Vancouver

Salama EE, Alrayes AA, Alrashdi S, Boraei ATA, Ahmed NI, Eid S, et al. Exploration of Novel Indole Compounds with Potential Activity Against Breast Cancer: Synthesis, Characterization and Anti-Cancer Activity Evaluation. Pharmaceuticals. 2026;19(3):418. doi:10.3390/ph19030418

BibTeX
@article{Salama2026,
  author = {Salama, Eid E and Alrayes, Ashtar A and Alrashdi, Saad and Boraei, Ahmed T A and Ahmed, Nagwa I and Eid, Salah and El-Nasser, Karam S and Kalil, Haitham and Sarhan, Ahmed A M},
  title = {Exploration of Novel Indole Compounds with Potential Activity Against Breast Cancer: Synthesis, Characterization and Anti-Cancer Activity Evaluation},
  journal = {Pharmaceuticals},
  year = {2026},
  volume = {19},
  number = {3},
  pages = {418},
  doi = {10.3390/ph19030418}
}
Kostenlos starten →